Zobrazeno 1 - 10
of 44
pro vyhledávání: '"AJ Dalby"'
Publikováno v:
European Heart Journal Supplements. 3:J24-J31
Options for antiplatelet therapy have increased in the last decade, with thienopyridines and GP IIb/IIIa receptor antagonists joining aspirin on the roster of available antiplatelet agents. Both North American (ACC/AHA) and European (ESC) cardiology
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4d1feff4a2af9e23327934ae67177f24
https://doi.org/10.1016/s1520-765x(01)90137-3
https://doi.org/10.1016/s1520-765x(01)90137-3
Autor:
AJ Dalby, Adrian David Marais, Dirk J. Blom, D Jankelow, M-R Taskinen, Eric Klug, Colin Schamroth, DA Webb, Frederick J. Raal, R Catsicas, Naomi Rapeport
Publikováno v:
Scopus-Elsevier
South African Family Practice; Vol 57, No 2 (2015); 22-31
South African Family Practice; Vol 57, No 2 (2015); 22-31
The European Society of Cardiology together with the European Atherosclerosis Society published updated dyslipidaemia guidelines in 2011. SA Heart and the Lipid and Atherosclerosis Society of Southern Africa officially adopt these guidelines. This st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fd1224b4441ab9e54146d96a1794a90
http://www.scopus.com/inward/record.url?eid=2-s2.0-84930163382&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-84930163382&partnerID=MN8TOARS
Autor:
Lopes RD; Duke University Medical Center, Duke Clinical Research Institute, Durham, NC. Electronic address: renato.lopes@dm.duke.edu., Guimarães PO; Heart Institute, InCor, University of São Paulo Medical School, São Paulo, Brazil., Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora, Colo., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, Mass., Bittner VA; University of Alabama at Birmingham, Birmingham, Ala., Budaj A; Centre of Postgraduate Medical Education, Grochowski Hospital, Warsaw, Poland., Dalby AJ; Life Fourways Hospital, Randburg, South Africa., Diaz R; Estudios Cardiológicos Latin América, Instituto Cardiovascular de Rosario, Rosario, Argentina., Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alta, Canada; St. Michael's Hospital, University of Toronto, Toronto, Ont, Canada., Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, Calif., Jukema JW; Leiden University Medical Center, Leiden, the Netherlands; Netherlands Heart Institute, Utrecht, the Netherlands., Kiss RG; Military Hospital, Budapest, Hungary., Loy M; Sanofi, Bridgewater, NJ., Pordy R; Regeneron Pharmaceuticals Inc., Tarrytown, NY., Poulouin Y; IT&M Stats, Neuilly-sur-Seine, France., Szarek M; Downstate School of Public Health, State University of New York, Brooklyn, NY; CPC Clinical Research and Division of Cardiology, University of Colorado School of Medicine, Aurora, Colo., White HD; Green Lane Cardiovascular Services, Auckland City Hospital, Auckland, New Zealand., Steg PG; Université de Paris, Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France; National Heart and Lung Institute, Royal Brompton Hospital, Imperial College, London, UK.
Publikováno v:
The American journal of medicine [Am J Med] 2022 Jul; Vol. 135 (7), pp. 915-918. Date of Electronic Publication: 2022 Mar 14.
Autor:
Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (R.H.M.F.).; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Raz I; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Goodrich EL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Bhatt DL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, ON, Canada (L.A.L.)., McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.)., Wilding JPH; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, United Kingdom (J.P.H.W.)., Aylward P; South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide (P.A.)., Dalby AJ; Life Fourways Hospital, Randburg, Republic of South Africa (A.J.D.)., Dellborg M; Sahlgrenska Academy, University of Gothenburg, Sweden (M.D.)., Dimulescu D; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (D.D.)., Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.)., Oude Ophuis AJM; Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands (A.J.M.O.O.)., Cahn A; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.)., Gause-Nilsson I; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Langkilde AM; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.)., Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.)., Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Publikováno v:
Circulation [Circulation] 2022 May 24; Vol. 145 (21), pp. 1581-1591. Date of Electronic Publication: 2022 May 05.
Autor:
Leiter LA; Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada; Departments of Medicine and Nutritional Sciences, University of Toronto, Toronto, Ontario, Canada. Electronic address: lawrence.leiter@unityhealth.to., Bhatt DL; Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School Boston, Boston, Massachusetts, USA. Electronic address: https://twitter.com/dlbhattmd., McGuire DK; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Teoh H; Division of Endocrinology and Metabolism, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada; Division of Cardiac Surgery, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, Ontario, Canada., Fox K; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom., Simon T; French Alliance for Cardiovascular Trials, Paris, France; Department of Clinical Pharmacology, Unité de Recherche Clinique, Assistance Publique-Hôpitaux de Paris, Hôpital Saint Antoine, Sorbonne Université, site St. Antoine, Institut National de la Santé et de la Recherche Médicale U-698, Paris, France., Mehta SR; Division of Cardiology, Population Health Institute, Hamilton Health Sciences Corporation, McMaster University, Hamilton, Ontario, Canada., Lev EI; Department of Cardiology, Assuta Ashdod Medical Center, Ashdod, Israel; Faculty of Health Sciences, Ben-Gurion University, Be'er Sheva, Israel., Kiss RG; Department of Cardiology, Military Hospital, Budapest, Hungary., Dalby AJ; Life Fourways Hospital, Randburg, Republic of South Africa., Bueno H; Department of Cardiology, Hospital Universitario 12 de Octubre, Madrid, Spain; Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain., Ridderstråle W; Late-Stage Development, Cardiovascular, Renal and Metabolic, Biopharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden., Himmelmann A; Late-Stage Development, Cardiovascular, Renal and Metabolic, Biopharmaceuticals Research & Development, AstraZeneca, Gothenburg, Sweden., Prats J; ELYSIS-Med Scientific Solutions, Carlisle, Massachusetts, USA., Liu Y; Baim Institute for Clinical Research, Boston, Massachusetts, USA., Lee JJ; Baim Institute for Clinical Research, Boston, Massachusetts, USA., Amerena J; Geelong Cardiology Research Unit, University Hospital Geelong, Barwon Health, Geelong, Victoria, Australia; Department of Cardiology, Deakin University, Geelong, Victoria, Australia; Department of Epidemiology and Preventative Medicine, Monash University, Victoria, Australia., Kosiborod MN; Department of Cardiology and Michael & Marlys Haverty Cardio Metabolic Center of Excellence, Saint Luke's Mid America Heart Institute, Kansas City, Missouri, USA; Department of Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA; The George Institute for Global Health, Sydney, New South Wales, Australia; University of New South Wales, Sydney, New South Wales, Australia., Steg PG; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom; French Alliance for Cardiovascular Trials, Paris, France; Université de Paris, Assistance Publique-Hôpitaux de Paris, Institut National de la Santé et de la Recherche Médicale 1148, Paris, France. Electronic address: https://twitter.com/gabrielsteg.
Publikováno v:
Journal of the American College of Cardiology [J Am Coll Cardiol] 2021 May 18; Vol. 77 (19), pp. 2366-2377.
Autor:
White HD; Green Lane Cardiovascular Service, Auckland City Hospital, University of Auckland, Auckland, New Zealand. Electronic address: harveyw@adhb.govt.nz., Stewart RAH; Green Lane Cardiovascular Service, Auckland City Hospital, University of Auckland, Auckland, New Zealand., Dalby AJ; Milpark Hospital, Johannesburg, Republic of South Africa., Stebbins A; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, and Harvard Clinical Research Institute, Harvard Medical School, Boston, MA., Budaj A; Postgraduate Medical School, Grochowski Hospital, Warsaw, Poland., Linhart A; 2nd Department of Medicine, Department of Cardiovascular Medicine, General University Hospital, Prague, Czech Republic., Pais P; St. John's Research Institute, Bangalore, India., Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Rosario, Argentina., Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, and Paris University, FACT (French Alliance for Cardiovascular Trials), INSERM, Paris, France; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom., Krug-Gourley S; Metabolic Pathways and Cardiovascular Therapeutic Area, GlaxoSmithKline, King of Prussia, PA., Granger CB; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Hochman JS; Department of Medicine, New York University Langone Medical Center, New York, NY., Koenig W; Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany; Deutsches Herzzentrum München, Technische Universität München, Munich, Germany; Deutsches Zentrum fur Herz-Kreislauf-Forschung (German Centre for Cardiovascular Research), partner site Munich Heart Alliance, Munich, Germany., Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, Stanford, CA., Held C; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden., Wallentin L; Department of Medical Sciences, Cardiology, Uppsala University, Uppsala, Sweden; Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
Publikováno v:
American heart journal [Am Heart J] 2020 Jul; Vol. 225, pp. 97-107. Date of Electronic Publication: 2020 Apr 18.
Autor:
Steg PG; Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université de Paris, FACT (French Alliance for Cardiovascular Trials), INSERM U1148, Paris, France (P.G.S.).; National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London, United Kingdom (P.G.S.)., Szarek M; State University of New York, Downstate School of Public Health, Brooklyn (M.S.)., Bhatt DL; Brigham and Women's Hospital Heart & Vascular Center and Harvard Medical School, Boston, MA (D.L.B.)., Bittner VA; Division of Cardiovascular Disease, University of Alabama at Birmingham. (V.A.B.)., Brégeault MF; Sanofi, Paris, France (M.F.B., C.H., G.L.)., Dalby AJ; Milpark Hospital, Johannesburg, Republic of South Africa (A.J.D.)., Diaz R; Estudios Cardiológicos Latinoamérica, Instituto Cardiovascular de Rosario, Argentina (R.D.)., Edelberg JM; Sanofi, Bridgewater, NJ (J.M.E., A.M.)., Goodman SG; Canadian VIGOUR Centre, University of Alberta, Edmonton, Canada and St. Michael's Hospital, University of Toronto, Canada (S.G.G.)., Hanotin C; Sanofi, Paris, France (M.F.B., C.H., G.L.)., Harrington RA; Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H., K.W.M.)., Jukema JW; Department of Cardiology, Leiden University Medical Center, the Netherlands (J.W.J.)., Lecorps G; Sanofi, Paris, France (M.F.B., C.H., G.L.)., Mahaffey KW; Stanford Center for Clinical Research, Department of Medicine, Stanford University, CA (R.A.H., K.W.M.)., Moryusef A; Sanofi, Bridgewater, NJ (J.M.E., A.M.)., Ostadal P; Na Homolce Hospital, Prague, Czech Republic (P.O.)., Parkhomenko A; Institute of Cardiology, Kyiv, Ukraine (A.P.)., Pordy R; Regeneron Pharmaceuticals Inc, Tarrytown, NY (R.P.)., Roe MT; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., P.T.).; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC (M.T.R.)., Tricoci P; Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (M.T.R., P.T.)., Vogel R; University of Colorado Denver (R.V.)., White HD; Green Lane Cardiovascular Services Auckland City Hospital, New Zealand (H.D.W.)., Zeiher AM; Department of Medicine III, Goethe University, Frankfurt am Main, Germany (A.M.Z.)., Schwartz GG; Division of Cardiology, University of Colorado School of Medicine, Aurora (G.G.S.).
Publikováno v:
Circulation [Circulation] 2019 Jul 09; Vol. 140 (2), pp. 103-112. Date of Electronic Publication: 2019 May 23.
Autor:
Bohula EA; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.) ebohula@partners.org., Wiviott SD; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.)., Giugliano RP; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.)., Blazing MA; Duke Clinical Research Institute, Durham, NC (M.A.B., J.A.W.)., Park JG; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.)., Murphy SA; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.)., White JA; Duke Clinical Research Institute, Durham, NC (M.A.B., J.A.W.)., Mach F; Cardiology Dvision, Geneva University Hospital, Switzerland (F.M.)., Van de Werf F; Departments of Cardiovascular Medicine and Cardiovascular Sciences, University of Leuven, Belgium (F.V.d.F.)., Dalby AJ; Milpark Hospital, Johannesburg, South Africa (A.J.D.)., White HD; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand (H.D.W.)., Tershakovec AM; Merck & Co., Inc, Kenilworth, NJ (A.M.T.)., Cannon CP; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.)., Braunwald E; TIMI Study Group, Department of Medicine, Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA (E.A.B., S.D.W., R.P.G., J.-G.P., S.A.M., C.P.C., E.B.).
Publikováno v:
Circulation [Circulation] 2017 Dec 19; Vol. 136 (25), pp. 2440-2450. Date of Electronic Publication: 2017 Sep 30.
Autor:
Dalby AJ; Milpark Hospital, Johannesburg, South Africa., Gottlieb S; Department of Cardiology, Shaare Zedek Medical Center, Jerusalem, Israel., Cyr DD; Duke Clinical Research Institute, Durham, NC, USA., Magnus Ohman E; Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA., McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center, Dallas, TX, USA., Ruzyllo W; Department of Coronary Artery Disease, Institute of Cardiology, Warsaw, Poland., Bhatt DL; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Wiviott SD; Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA., Winters KJ; Eli Lilly and Company, Indianapolis, IN, USA., Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, Scotland, United Kingdom., Armstrong PW; Canadian VIGOUR Centre and Division of Cardiology, Department of Medicine, University of Alberta, Edmonton, Alberta, Canada., White HD; Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand., Prabhakaran D; Centre for Chronic Disease Control and Public Health Foundation of India, New Delhi, India., Roe MT; Duke Clinical Research Institute, Durham, NC, USA; Division of Cardiology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Electronic address: matthew.roe@duke.edu.
Publikováno v:
American heart journal [Am Heart J] 2017 Jun; Vol. 188, pp. 156-166. Date of Electronic Publication: 2017 Mar 27.
Autor:
Eisen A; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Braunwald E; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Steen DL; University of Cincinnati, OH., Zhou J; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Goodrich EL; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Im K; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA., Dalby AJ; Milpark Hospital, Johannesburg, South Africa., Spinar J; University Hospital Brno, Brno, Czech Republic., Daga S; GlaxoSmithKline, Philadelphia, PA., Lukas MA; GlaxoSmithKline, Philadelphia, PA., O'Donoghue ML; Cardiovascular Division, Brigham and Women's Hospital, Boston, MA modonoghue@partners.org.
Publikováno v:
Journal of the American Heart Association [J Am Heart Assoc] 2017 Jan 11; Vol. 6 (1). Date of Electronic Publication: 2017 Jan 11.